Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dapsone plus intralesional antimoniate for cutaneous leishmaniasis
IRCT20140211016554N4Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dapsone in cutaneous leishmaniasis (CL), sponsored by Mashhad University of Medical Sciences. Started Jun 2012; status: completed.
02
Drugs
dapsone
03
Conditions
cutaneous leishmaniasis (CL)
Beyond the preview
Go deeper on IRCT20140211016554N4.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140211016554N4.